Literature DB >> 25479208

Development and validation of the Functional Rhinoplasty Outcome Inventory 17 (FROI-17).

Cem Bulut, Frank Wallner, Peter K Plinkert, Ingo Baumann.   

Abstract

STATEMENT OF PROBLEM: Quality of life aspects become more and more important in all fields of medicine. There is a lack of such instruments for septorhinoplasty that cover sufficiently both functional and aesthetic aspects.
METHODOLOGY: In Phase 1, a group of experts identified 22 questions that represent the symptoms of patients with nasal deformities, which undergo a functional and aesthetic nasal surgery. Forty-one patients filled out the questionnaires before septorhinoplasty. The item assessment and item reduction was performed by a sequential statistical analysis, which included a single item analysis, an assessment of internal consistency, construct validity, the divergence validity and a factor analysis. The resulting 17-item questionnaire was used in a prospective validation study (Phase 2) in which 103 patients were enrolled. Statistical analysis included testing of validity, reliability and responsiveness.
RESULTS: In Phase 2 data analysis revealed a good internal consistency and significant test-retest reliability. A literature survey confirmed that the relevant items were included in the questionnaire. We found significant item-score-correlations. Furthermore, the existence of concurrent validity was confirmed. Standardized Response Mean (SRM) as a measure for sensitivity to change indicated moderate to large effects.
CONCLUSION: FROI-17 is a valid quality of life instrument for use in septorhinoplasty patients. The instrument is now available for prospective data collection in future septorhinoplasty outcome studies.

Entities:  

Mesh:

Year:  2014        PMID: 25479208     DOI: 10.4193/Rhino13.098

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  8 in total

1.  Quality of life in functional rhinoplasty: rhinoplasty outcomes evaluation German version (ROE-D).

Authors:  Olcay Cem Bulut; Peter K Plinkert; Frank Wallner; Ingo Baumann
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-10       Impact factor: 2.503

Review 2.  A systematic review of patient-reported outcome measures after rhinoplasty.

Authors:  M Barone; A Cogliandro; N Di Stefano; V Tambone; P Persichetti
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-31       Impact factor: 2.503

3.  Long-term quality of life changes after primary septorhinoplasty.

Authors:  Olcay Cem Bulut; Frank Wallner; Dare Oladokun; Claire Kayser; Michaela Plath; Eric Schulz; Peter Karl Plinkert; Ingo Baumann
Journal:  Qual Life Res       Date:  2017-12-04       Impact factor: 4.147

4.  Impact of Le-Fort I osteotomy on anatomical and functional aspects of the nasal airway and on quality of life.

Authors:  Karim Zaoui; Reinald Kuehle; Ingo Baumann; Dorothee Laura Schuessler; Oliver Ristow; Michaela Plath; Christian Freudlsperger
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-14       Impact factor: 2.503

5.  Development and Psychometric Evaluation of the FACE-Q Scales for Patients Undergoing Rhinoplasty.

Authors:  Anne F Klassen; Stefan J Cano; Charles A East; Stephen B Baker; Lydia Badia; Jonathan A Schwitzer; Andrea L Pusic
Journal:  JAMA Facial Plast Surg       Date:  2016 Jan-Feb       Impact factor: 4.611

6.  How to predict the outcome of septorhinoplasty? A normative study of ROE and FROI-17 scores.

Authors:  Michaela Plath; Matthias Sand; Carlo Cavaliere; Peter K Plinkert; Ingo Baumann; Karim Zaoui
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-08       Impact factor: 2.124

7.  The 10-Item Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) for Functional and Cosmetic Rhinoplasty.

Authors:  Sami P Moubayed; John P A Ioannidis; Mikhail Saltychev; Sam P Most
Journal:  JAMA Facial Plast Surg       Date:  2018-01-01       Impact factor: 4.611

8.  Tumor Control and Quality of Life in Skin Cancer Patients With Extensive Multilayered Nasal Defects.

Authors:  Michaela Plath; Hannah M Thielen; Ingo Baumann; Karim Zaoui; Philippe A Federspil
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-08-03       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.